verapamil has been researched along with bibw 2992 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basetti, V; Keesara, M; Maiti, P; Mansour, TS; Moghudula, AG; Pallepati, RR; Potluri, V | 1 |
| Huo, X; Liu, K; Liu, Q; Liu, Z; Ma, X; Meng, Q; Sun, H; Sun, P; Wang, C; Yang, X; Zhang, Y | 1 |
2 other study(ies) available for verapamil and bibw 2992
| Article | Year |
|---|---|
Lead generation of 1,2-dithiolanes as exon 19 and exon 21 mutant EGFR tyrosine kinase inhibitors.
Topics: Exons; Humans; Mutation; Protein Kinase Inhibitors; Thioctic Acid | 2019 |
P-gp is involved in the intestinal absorption and biliary excretion of afatinib in vitro and in rats.
Topics: Adenosine Triphosphatases; Afatinib; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bile; Biological Transport; Caco-2 Cells; Cell Line, Tumor; Cyclosporine; Hepatobiliary Elimination; Hepatocytes; Humans; Intestinal Absorption; Intestinal Mucosa; Intestines; Male; Quinazolines; Rats; Rats, Wistar; Verapamil | 2018 |